FibroGen (FGEN) Reports Q4 Loss, Lags Revenue Estimates
28/2 23:45
FibroGen (FGEN) came out with a quarterly loss of $1.45 per share versus the Zacks Consensus Estimate of a loss of $0.68. This compares to loss of $0.64 per share a year ago. These figures are adjusted for non-recurring items....